1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

25 May 2024
Admin
News Article

Cambridge Biotherapies Launches Ketamine Infusions for Pain and Headache Management

Overview

Cambridge Biotherapies, a leading mental health treatment provider in Massachusetts, announced the launch of Ketamine Infusions for pain and headache management, now available at all locations.

This new service underscores the organization's commitment to providing revolutionary treatments that can significantly improve the quality of life for patients suffering from chronic pain and migraine headaches.

Ketamine Infusions for Pain Management

Cambridge Biotherapies' Ketamine Infusions for Pain Management positions the facility as a leader in innovative pain management solutions, offering patients access to a treatment modality with proven effectiveness in alleviating chronic pain and migraine headaches.
As one of the fastest growing psychiatrist-led facilities offering ketamine infusion treatments in Boston and the surrounding areas, Cambridge Biotherapies provides a unique, holistic experience in a homey and comfortable setting.

Mental Health Conditions in Massachusetts

Massachusetts is facing a growing mental health crisis, with increasing numbers of residents seeking effective treatment for mental health and chronic pain conditions.
By expanding services across all locations in Amherst, Beverly, and Cambridge, Cambridge Biotherapies is committed to meeting the rising demand for comprehensive mental health care.
The addition of Ketamine Infusions for pain and headache management is a direct response to the need for innovative, effective treatment options in the region.

Alternative to Opioids: Ketamine for pain is an emerging treatment option, providing a direct alternative to opioids amidst the opioid crisis, with controlled pain management.
Access to Effective Treatment: Patients gain access to a new, effective treatment option that may provide relief where other methods have failed.

Commitment to cutting-edge treatment: This launch demonstrates Cambridge Biotherapies' dedication to continually providing advanced treatment options that can improve patients' quality of life.

About Ketamine Infusions

According to recent studies, Ketamine Infusions have shown significant effectiveness in reducing pain for patients with various chronic pain conditions.
A study published in the Journal of Pain Research found that 75% of patients with Complex Regional Pain Syndrome (CRPS) experienced significant pain relief after receiving Ketamine Infusions.
Additionally, research indicates reduced overall opioid use compared to control groups, highlighting ketamine's potential as a safer pain management option.

From MD: Cambridge Biotherapies

"At Cambridge Biotherapies, we are dedicated to transforming mental health and pain management by offering the most innovative and effective treatments available,"" said Daniel Brenner, M.D., founder and medical director of Cambridge Biotherapies.
"Our new Ketamine Infusions for pain management provide hope and relief for patients who have struggled with chronic pain, giving them a new lease on life.""

Ketamine Infusions for American population

With over 50 million Americans seeking mental health treatment annually, the addition of Ketamine Infusions for pain management provides an essential service that addresses both mental health and chronic pain, offering holistic care that integrates mental and physical health support.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!